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Book review
Disease management: a systems approach to improving
patient outcomes
Edited by Warren E. Todd, David Nash,
San Francisco: Jossey-Bass, 1997, pp. 357,
ISBN 1-55648-168-3
This book contains 12 chapters written by 30 authors,
52 figures, 35 tables, 384 references and 357 pages.
It is a real How to-Book written by authors who are
eager to explain what Disease Management (DM) is
and to instruct the readers how to develop it in their
own company or country. Most definitions and instruc-
tions are accompanied by organisational schemes,
flow charts for developmental processes, case studies
of best practices and references. It is too much to dis-
cuss in a book review all knowledge of each chapter.
That’s why I concentrate on those topics, which are
also interesting for non-Americans.
Chapter 1 introduces the concept of disease manage-
ment, two words used for the first time by the Boston
Consultancy Group in 1993. The authors situate the
concept between Component Management and
Health Management. A component is an organisation-
al unit, for instance a hospital or a home care organi-
sation. Component management is the traditional way
of managing hospitals and other health care organi-
sations. Health management has as objective the
health of a target group: the group of insured persons
of an insurance company, the workers of a company
or the local population of a municipality or province.
Not only care is managed but also all social and pre-
ventive services, such as adaptation of the work place
of a disabled person or a special school for children
with a chronic condition. Health management is
beyond disease management and is discussed in the
last chapter in this book.
Between Component Management and Health Man-
agement there is Disease Management, with six defin-
ing aspects:
1. Understanding the course of the disease to which
the disease management programme or system is
focused. The difference between a programme and
a system is that the first one is more loosely organ-
ised than the last one. The title of this book con-
tains the words Systems Approach, which
emphasises the authors’ preferences for systems.
Most disease management systems are focused on
diseases as AsthmayCOPD, diabetes, depression,
cardiovascular disease and cancer. All of these
conditions have an understood course of the
disease.
2. Targeting patients likely to benefit from interven-
tions. Using the knowledge of the course of the dis-
ease and the costs of each phase of it, a disease
management system focuses its activities on
patients in that phase in which costs are high and
alternative interventions available. As an example
is Figure 1.1 in the book showing costs of care per
month of a depressed person. During the diagnosis
phase as distinguished costs per month are high.
3. Focusing on Prevention and Resolution. Although
generally formulated the authors reduce the con-
cept of prevention to advice on diets, exercise, non-
smoking, alcohol consumption and other lifestyle
advices to individual patients. Resolution is in this
context the use of only Evidence Based Medical
Treatment.
4. Increasing Patient Compliance through Education.
An important part of disease management is patient
education to promote the compliance with (phar-
maco) therapy and other medical treatment. There
is an overlap with point 3, which emphasises the
compliance with advised preventive coping
behaviour.
5. Providing Full Care Continuity. The authors fill in
this aspect with ‘‘aggressive case management (...)
to plan and monitor treatment across all settings.
The goal would be to avoid problems and to keep
the patient out of the expensive (...) settings’’.
6. Establishing Integrated Data Management Sys-
tems. The importance of sophisticated data sys-
tems with disease management programmes
cannot be overstated. Computerised patient
records and auotomated surveys are necessary.
The greatest obstacle to the success of disease
management is the current lack of integrated data
management.
Chapter 2 discusses the development towards dis-
ease management during the last twenty years. Impor-
tant for Europeans is the observation that fee-
for-service systems are old-fashioned: they form the
first step towards disease management. The second
step is utilisation review within the fee for service sys-
tems. Thirdly is the occurrence of Managed Care
Organisations. During the fourth phase the diseaseInternational Journal of Integrated Care – Vol. 2, 1 March 2002 – ISSN 1568-4156 – http://www.ijic.org/
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Figure 1.1. A disease cost model for depression.
management systems are dominant. During the final
phase these systems have made place for Population
Based Health Management Systems, which were
already mentioned in Chapter 1. To develop a disease
management System Chapter 2 shows flow charts
with implementation strategies. One of them is Figure
2.2
Chapter 3 on Health Outcomes of Disease Manage-
ment is less interesting for health services researchers
who are familiar with Cost Effectiveness Analysis and
Medical Technology Assessment. However, the author
emphasises that knowledge is not enough to imple-
ment Evidence Based Medicine in a disease manage-
ment setting.
Chapter 4 discusses financial and actuarial issues of
disease management. The authors can be compli-
mented that they do not teach the basics of financial
accounting and budgeting. They go immediately to
issues specially related to disease management. They
introduce the yearly treatment costs per patient group
by percentiles. This is known as the 20–80 rule: 20%
of all patients consume 80% of the costs. Disease
management should focus on this 20%. Another new
economic indicator is the costs by type of encounter
and by type of episode. The authors distinguish as
encounters for example regular Out Patient Depart-
ment visits, emergency room visits and admissions.
Episodes can be periods during which a disease is
active, which can be the case with Asthma; periods
corresponding to specific drug regimens or a stage of
a progressive disease, such as AIDS.
Chapter 5 discusses the selection of a disease man-
agement system. The authors introduce three selec-
tion criteria:
1. the impact of the disease on costs and quality,
2. the availability of interventions and
3. the potential value of disease management for cost
control and quality improvement.
Somewhat disillusioning for the European reader are
the economic considerations to select a patient group
for a disease management programme. Not the con-
tinuity of care or the multidisciplinary approach of the
providers are the decisive factors but economic rea-
sons. For instance the ‘‘patients with the highest
aggregate payments per care episodes’’ are very inter-
esting for disease management.
Chapter 6 focuses on identification, selection, evalu-
ation, modification, dissemination and implementation
of Clinical Practice Guidelines in disease management
systems. The authors underline that evaluation and
periodic review of the guidelines in the own disease
management organisation is important. Everything in
this chapter is true, but the book reviewer had the feel-
ing of a sentimental journey: coming back to already
known places.
Chapter 7 discusses the role of Pharmaceutical com-
panies in disease management, which are the found-
ing fathers of the idea of disease management. This
is firstly a historical chapter showing how disease
management was primarily distrusted because of itsInternational Journal of Integrated Care – Vol. 2, 1 March 2002 – ISSN 1568-4156 – http://www.ijic.org/
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Figure 2.2. Systems-thinking model: the disease management process.
pharmaceutical background and how it got later its
own value because of its six main aspects, mentioned
in Chapter 1. The authors finish their contribution by
presenting a questionnaire to assess Pharmaceutical
Industry Disease Management Programmes. The
book reviewer thinks that the questionnaire can be
used for more disease management systems than
only those, which are owned by Drugs companies.
Chapter 8 describes the role of disease management
within Managed Care Organisations. The authors give
a historical overview that is comparable, or, negatively
formulated, an overlap, with that in Chapter 2. They
mention five performance indicators for Asthma dis-
ease management system: frequency of exacerbation,
changes in severity or functional health status, fre-
quency of physician and emergency room visits, med-
ication usage and workyschool days missed. As best
disease management practices they present a Dia-
betes- and an Asthma programme. Combining this
with best practices mentioned in other chapters I got
the impression that disease management is mostly
involved with these diseases.
Chapter 9 shows the role of case management without
and with disease management. Prior to disease man-
agement, case managers have an individual patient
focus, intervene within only one and the same clinical
episode, and try to prevent hospitalisation, have a
short-term relationship with a patient and work only
within the domain by whom they are paid. According
to the authors, this all changes after the introduction
of disease management. Then, case managers have
a population focus, do also preventive and educational
interventions, and try to prevent illness, have a long-
term relationship and work also outside the domain of
the payers. Although it is interesting to read about the
differences, it is unclear what the authors describe: the
nowadays reality of disease management or wishfully
thinking about it?
Chapter 10 has as title Home Care and Disease Man-
agement. However, it is more a description of the
American Home Care Industry. The chapter is inter-
esting because of its emphasis on clinical pathways,
which are not discussed until this chapter. The authors
argue to analyse the practice patterns of care delivery
and to split these up in disease components. Then the
home care activities can be defined. What I missed in
this chapter is a discussion of nurse general practi-
tioners versus nurse specialists. Who is the most
important nurse in a disease management programme
for diabetes patients: a general educated case man-
ager or a nursing diabetes specialist?International Journal of Integrated Care – Vol. 2, 1 March 2002 – ISSN 1568-4156 – http://www.ijic.org/
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Figure 12.5. Shifting health information paradigms.
Chapter 11 discusses the necessity to form alliances
between health care providers to create a disease
management system. The authors argue that an alli-
ance is the most difficult way of cooperating. Easier is
an internal corporation: all disciplines are available
within the same health care organisation. By top down
redesigning the care process a disease management
programme is created. External corporation is also
easier: then one company buys in the services of
another company. It is clear what the dominant actor
is and regulations are simply made. The extended cor-
poration, in which two or more corporations cooperate
without merging with each other and without buying
and selling to each other, is most complicated. Follow-
ing the authors, three basic criteria for ideal alliances
are:
1. they must be long term relationships,
2. they must be built on close operational ties and
3. they must have true vested interest in each ally’s
future.
This chapter gives a lot of amusing case studies about
successful and disappointing alliances.
Chapter 12 is the last chapter and discusses Health
Management as defined in the first chapter. It shows
us the Promised Land of the disease management
believer. There is health optimised, health risks min-
imised, specific diseases are prevented, early diag-
noses are facilitated, clinical effectiveness is
maximised and complications of diseases are avoided.
There, unnecessary care is eliminated and care qualityInternational Journal of Integrated Care – Vol. 2, 1 March 2002 – ISSN 1568-4156 – http://www.ijic.org/
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continuously improved. Although all these objectives
are inspiring, intellectually two other topics are more
interesting. The first one is the argument for a shift in
the health information paradigm (see Figure 12.5).
The information is not dominantly collected in the third
tier, for instance within the big hospitals but in the pop-
ulation itself: the self-caring patients, their friend and
families. The second point is the plea for integration
of disease management programmes with occupation-
al health agencies. Then a health management pro-
gramme for the working population is possible.
Because many American Managed Care Organisa-
tions with disease management are linked to big
employers, this option is not that far away as the
Promised Land in the beginning of the chapter.
The strength of this book is the enthusiasm of the
authors, the clear definitions, flow charts and step-by-
step approaches. Sometimes, this is also its weakness
when the authors do not distinguish enough between
facts and dreams or when they reduce the complex
disease management world to one single scheme.
However, readers of the International Journal of inte-
grated Care should buy the book when they need def-
initions, indicators and historical overviews. Hopefully,
an updated version of this book of 1997 is published
in the coming years.
P.S.
Having finished this book review I received the report
DISEASE MANAGEMENT ONLINE, CRITICAL
INGREDIENTS FOR SUCCESS, which can be con-
sidered as an update of the above reviewed book. All
emphasis is given to the use of Internet for education
and empowerment of the patient. Some doctors hesi-
tate to meet very well informed patients who consulted
disease management websites between two consul-
tations. Anyhow, some (not scientific published)
results show that at the end of the day, well informed
patients have more compliance with the therapy than
not informed persons.
Nevertheless, many problems have to be solved. How
to identify that the surferyloginner is indeed the patient
self? How to organize a virtual helpdesk if the website
does not contain a prepared answer? Who is respon-
sible for the electronically given advices? The authors
give some beginning of the solutions for these ques-
tion. But, the answers are not completely satisfying.
The report can be ordered at
www.themsic.com or at
Disease Management Online, Critical ingredients for
Success, presented by e-healthcare Market reporter
and the managed Care Information Center,
Managed Care Information Center
1913 Atlantic Avenue, Suite F4
Manasquan, NJ 08736
USA
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